A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.
Clinical trial NCT03290443 · COMPLETED
Trial details
- NCT number
- NCT03290443
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2018-10-26
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.